Insiders Basilea Pharmaceutica AG

Equities

BSLN

CH0011432447

Delayed Swiss Exchange Other stock markets 16:31:55 08/05/2024 BST			5-day change	1st Jan Change
42.85 ^CHF	+5.28%		+8.48%	+21.39%

05-03	Basilea Reports Presentation of New Data for Ceftobiprole (Zevtera®) At Escmid Global 2024	CI
04-09	Basilea Pharmaceutica Receives Grant for Antibiotics Program	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Basilea Pharmaceutica Ltd. Approves Appointment of Leonard Kruimer as New Member of Board and as Chairman of the Audit Committee	13/04/22	CI
Basilea Pharmaceutica AG Appointment of Savitha Ram Moorthi as New Head of Global Quality Management	29/04/20	CI
Basilea announces change in the Management Committee - Adesh Kaul appointed CFO	07/02/19	GL
Basilea Pharmaceutica : announces change in the Management Committee - Adesh Kaul appointed CFO	07/02/19	GL
Basilea Pharmaceutica Ltd. Announces Management Changes	27/04/18	CI
Basilea Pharmaceutica Ltd. Appoints Adesh Kaul as Chief Corporate Development Officer	01/03/18	CI
Basilea Pharmaceutica : CEO Ronald Scott will retire. Chief Commercial Officer David Veitch named as successor. Changes in the Board of Directors	21/02/18	GL
Basilea Pharmaceutica Ltd. Announces Executive Changes	21/02/18	CI
Basilea Pharmaceutica : Chief Medical Officer Prof. Achim Kaufhold to retire and Dr. Marc Engelhardt named as successor	31/10/17	GL
Basilea Pharmaceutica Announces Management Changes	31/10/17	CI
Basilea Pharmaceutica Ltd. Announces Executive Changes	02/06/17	CI
Basilea Pharmaceutica Ltd. Elects Nicole Onetto as a New Member of Board of Directors	27/04/17	CI
Basilea Pharmaceutica Ltd. to Appoint Dr. Nicole Onetto as a Non-Executive Member of the Board, Effective on April 27, 2017	27/02/17	CI
Basilea Pharmaceutica Ltd. Announces Executive Changes	29/12/16	CI
Basilea Pharmaceutica Ltd. Announces Management Changes	15/03/16	CI
Basilea Pharmaceutica : Head of Global Human Resources, Heidi Mc Daid, to retire and Ursula Eberhardt named as successor	29/12/15	GL
Basilea Pharmaceutica Ltd. Announces Executive Changes, Effective from February 1, 2016	28/08/15	CI
Basilea Pharmaceutica : Chief Technology Officer Dr. Ingrid Heinze-Krauss to retire and Dr. Günter Ditzinger named as successor	28/08/15	GL
Basilea Pharmaceutica Ltd. Appoints David Veitch as Chief Commercial Officer, Effective September 1, 2014	18/08/14	CI
Basilea Pharmaceutica AG Announces Board Changes	09/04/13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Basilea Pharmaceutica AG

Equities

BSLN

CH0011432447

Insiders

Filters